These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9624021)

  • 1. Macular edema associated with nicotinic acid (niacin).
    Callanan D; Blodi BA; Martin DF
    JAMA; 1998 Jun; 279(21):1702. PubMed ID: 9624021
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cystoid macular edema].
    Neu F
    Bull Soc Belge Ophtalmol; 2007; (304):71-6. PubMed ID: 17718230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low HDL cholesterol levels.
    Pollock JL
    N Engl J Med; 2006 Jan; 354(4):417-9; author reply 417-9. PubMed ID: 16444813
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathophysiological hypothesis regarding the role of nicotinamide in the genesis of niacin-induced macular edema].
    Trechot P; Conart JB; Trechot F; Petitpain N; Angioi K; Berrod JP
    J Fr Ophtalmol; 2014 Apr; 37(4):e49-51. PubMed ID: 24629445
    [No Abstract]   [Full Text] [Related]  

  • 5. Optical coherence tomography findings in niacin maculopathy.
    Dajani HM; Lauer AK
    Can J Ophthalmol; 2006 Apr; 41(2):197-200. PubMed ID: 16767207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystoid macular edema from niacin typically is not accompanied by fluorescein leakage on angiography.
    Bressler NM
    Am J Ophthalmol; 2005 May; 139(5):951; author reply 951. PubMed ID: 15860328
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic acid maculopathy. 1973.
    Gass JD
    Retina; 2003 Dec; 23(6 Suppl):500-10. PubMed ID: 15035390
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectral domain optical coherence tomography features in niacin maculopathy.
    Courtney RJ; Singh RP
    Eye (Lond); 2014 May; 28(5):629-32. PubMed ID: 24577254
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse ocular effects associated with niacin therapy.
    Fraunfelder FW; Fraunfelder FT; Illingworth DR
    Br J Ophthalmol; 1995 Jan; 79(1):54-6. PubMed ID: 7880795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A rare case of cystoid maculopathy].
    Rahman W; Errera MH; Egan C
    J Fr Ophtalmol; 2013 Feb; 36(2):e33-6. PubMed ID: 23218599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic challenges.
    Davis MJ; Ravage ZB; Packo KH; Arevalo JF; Bernstein PS; Berger AS
    Retina; 2008 Mar; 28(3):520-4. PubMed ID: 18327149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Enduracin--a nicotinic acid preparation in the treatment of hypercholesterolemia].
    Kardiologiia; 1993; 33(11):67-80. PubMed ID: 8145429
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicotinic acid-induced fulminant hepatic failure.
    Clementz GL; Holmes AW
    J Clin Gastroenterol; 1987 Oct; 9(5):582-4. PubMed ID: 3680913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin caution.
    Gorrell RL
    Postgrad Med; 1991 Mar; 89(4):262. PubMed ID: 2000360
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe reversible hyperglycemia as a consequence of niacin therapy.
    Schwartz ML
    Arch Intern Med; 1993 Sep; 153(17):2050-2. PubMed ID: 8357290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin treatment of hypercholesterolemia in children.
    Colletti RB; Neufeld EJ; Roff NK; McAuliffe TL; Baker AL; Newburger JW
    Pediatrics; 1993 Jul; 92(1):78-82. PubMed ID: 8516088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular side effects from herbal medicines and nutritional supplements.
    Ciardella AP
    Am J Ophthalmol; 2005 May; 139(5):950; author reply 950. PubMed ID: 15860325
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with crystalline niacin as the preferred drug for dyslipidemia in a specialty clinic.
    Rindone JP; Arriola OG
    Pharmacotherapy; 1997; 17(6):1296-9. PubMed ID: 9399614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with fluvastatin and niacin in hypercholesterolemia: a preliminary report on safety.
    Jacobson TA; Amorosa LF
    Am J Cardiol; 1994 May; 73(14):25D-29D. PubMed ID: 8198020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.